Expression of bone morphogenetic protein 2, 4, 5, and 7 correlates with histological activity of otosclerotic foci

Acta Oto-Laryngologica

Volumn 132, Issue 6, 2012, Pages 624-631

  Csomor, Péter ^a   Liktor, Balázs ^b   Liktor, Bálint ^b   Szekanecz, Zoltán ^a   Sziklai, István ^a   Karosi, Tamás ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b BAJCSY ZSILINSZKY HOSPITAL   (Hungary)

Author keywords

Bone remodeling disorder; Non otosclerotic stapes fixation; Stapes

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 5; BONE MORPHOGENETIC PROTEIN 9;

ADULT; AGED; ARTICLE; BONE TURNOVER; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; MALE; OTOSCLEROSIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAPES;

ADULT; AGED; BIOLOGICAL MARKERS; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 5; BONE MORPHOGENETIC PROTEIN 7; BONE REMODELING; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; OTOSCLEROSIS; PROGNOSIS; STAPES; STAPES SURGERY;

EID: 84861034935     PISSN: 00016489     EISSN: 16512553     Source Type: Journal    
DOI: 10.3109/00016489.2011.653669     Document Type: Article

References (20)

1. Chole RA, McKenna M. Pathophysiology of otosclerosis. Otol Neurotol 2001;22:249-57.
2. Stankovic KM, Adachi O, Tsuji K, Kristiansen AG, Adams JC, Rosen V, et al. Differences in gene expression between the otic capsule and other bones. Hear Res 2010; 265:83-9.
3. Declau F, Van Spaendonck M, Timmermans JP, Michaels L, Liang J, Qiu JP, et al. Prevalence of otosclerosis in an unselected series of temporal bones. Otol Neurotol 2001;22:596-602. (Pubitemid 32845631)
4. Karosi T, Csomor P, Petkó M, Liktor B, Szabó LZ, Pytel J, et al. Histopathology of nonotosclerotic stapes fixations. Otol Neurotol 2009;30:1058-66.
5. McKenna MJ, Mills BG, Galey FR, Linthicum FH Jr. Filamentous structures morphologically similar to viral nucleocapsids in otosclerotic lesions in two patients. Am J Otol 1986;7:25-8. (Pubitemid 16188442)
6. Van Den Bogaert K, Govaerts PJ, De Leenheer EM, Schatteman I, Verstreken M, Chen W, et al. Otosclerosis: a genetically heterogeneous disease involving at least three different genes. Bone 2002;30:624-30. (Pubitemid 34270502)
7. McKenna MJ, Kristiansen AG, Bartley ML, Rogus JJ, Haines JL. Association of COL1A1 and otosclerosis: evidence for a shared genetic etiology with mild osteogenesis imperfecta. Am J Otol 1998;19:604-10. (Pubitemid 28409415)
8. Lehnerdt G, Unkel C, Metz KA, Jahnke K, Neumann A. Immunohistochemical evidence of BMP-2, -4 and -7 activity in otospongiosis. Acta Otolaryngol 2008;128:13-17.
9. Thys M, Schrauwen I, Vanderstraeten K, Janssens K, Dieltjens N, Van Den Bogaert K, et al. The coding polymorphism T263I in TGF-beta1 is associated with otosclerosis in two independent populations. Hum Mol Genet 2007; 16:2021-30. (Pubitemid 47354885)
10. Karosi T, Szalmás A, Csomor P, Kónya J, Petkó M, Sziklai I. Disease-associated novel CD46 splicing variants and pathologic bone remodeling in otosclerosis. Laryngoscope 2008; 118:1669-76.
11. Schrauwen I, Ealy M, Huentelman MJ, Thys M, Homer N, Vanderstraeten K, et al. A genome-wide analysis identifies genetic variants in the RELN gene associated with otosclerosis. Am J Hum Genet 2009;84:328-38.
12. Lehnerdt G, Metz KA, Trellakis S, Jahnke K, Neumann A. Signaling by way of type IB and II bone morphogenetic protein receptors regulates bone formation in otospongiosis. Laryngoscope 2007;117:812-16. (Pubitemid 46699349)
13. de Gorter DJ, van Dinther M, Korchynskyi O, Ten Dijke P. Biphasic effects of transforming growth factor b on bone morphogenetic protein-induced osteoblast differentiation. J Bone Miner Res 2011;26:1178-87.
14. Liu W, Butts S, Kim H, Frenz DA. Negative regulation of otic capsule chondrogenesis: it can make you Smad. AnnNY Acad Sci 2007;1116:141-8. (Pubitemid 350274313)
15. Brown DJ, Kim TB, Petty EM, Downs CA, Martin DM, Strouse PJ, et al. Autosomal dominant stapes ankylosis with broad thumbs and toes, hyperopia, and skeletal anomalies is caused by heterozygous nonsense and frameshift mutations in NOG, the gene encoding noggin. Am J Hum Genet 2002; 71:618-24. (Pubitemid 34970132)
16. Schrauwen I, Thys M, Vanderstraeten K, Fransen E, Dieltjens N, Huyghe JR, et al. Association of bone morphogenetic proteins with otosclerosis. J Bone Miner Res 2008;23: 507-16. (Pubitemid 351501891)
17. Harris SE, Bonewald LF, Harris MA, Sabatini M, Dallas S, Feng JQ, et al. Effects of transforming growth factor beta on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long-term cultures of fetal rat calvarial osteoblasts. J Bone Miner Res 1994;9:855-63.
18. Zheng MH, Wood DJ, Wysocki S, Papadimitriou JM, Wang EA. Recombinant human bone morphogenetic protein-2 enhances expression of interleukin-6 and transforming growth factor-beta 1 genes in normal human osteoblast-like cells. J Cell Physiol 1994;159:76-82. (Pubitemid 24234579)
19. Karosi T, Jókay I, Kónya J, Petkó M, Szabó LZ, Pytel J, et al. Activated osteoclasts with CD51/61 expression in otosclerosis. Laryngoscope 2006;116:1478-84. (Pubitemid 44181468)
20. Csomor P, Sziklai I, Liktor B, Szabó L, Pytel J, Jóri J, et al. Otosclerosis: disturbed balance between cell survival and apoptosis. Otol Neurotol 2010;31:867-74.